We are live on ! Find out more
NFSG

Newbridge Financial Services Group Portfolio holdings

AUM $608M
1-Year Est. Return 31.28%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+31.28%
3 Year Est. Return
+114.56%
5 Year Est. Return
+128.99%
10 Year Est. Return
AUM
$163M
AUM Growth
+$27.3M
Cap. Flow
+$14.4M
Cap. Flow %
8.83%
Top 10 Hldgs %
23.19%
Holding
1,560
New
190
Increased
483
Reduced
228
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Consumer Discretionary 14.78%
3 Financials 6.76%
4 Communication Services 6.68%
5 Healthcare 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLM icon
1301
SLM Corp
SLM
$5.09B
$2K ﹤0.01%
88
SNPS icon
1302
Synopsys
SNPS
$75.1B
$2K ﹤0.01%
8
SPEU icon
1303
State Street SPDR Portfolio Europe ETF
SPEU
$732M
$2K ﹤0.01%
54
+21
+64% +$884
STAA icon
1304
STAAR Surgical
STAA
$1.21B
$2K ﹤0.01%
+13
New +$1.71K
TAK icon
1305
Takeda Pharmaceutical
TAK
$53.7B
$2K ﹤0.01%
128
TNK icon
1306
Teekay Tankers
TNK
$2.79B
$2K ﹤0.01%
150
TREX icon
1307
Trex
TREX
$4.66B
$2K ﹤0.01%
22
TTWO icon
1308
Take-Two Interactive
TTWO
$45.8B
$2K ﹤0.01%
9
+6
+200% +$1.06K
VALE icon
1309
Vale
VALE
$62B
$2K ﹤0.01%
75
VANI icon
1310
Vivani Medical
VANI
$115M
$2K ﹤0.01%
104
VBR icon
1311
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
$2K ﹤0.01%
11
VLUE icon
1312
iShares MSCI USA Value Factor ETF
VLUE
$9.21B
$2K ﹤0.01%
17
GMDA
1313
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$2K ﹤0.01%
378
MRTX
1314
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2K ﹤0.01%
10
MYOV
1315
DELISTED
Myovant Sciences Ltd.
MYOV
$2K ﹤0.01%
88
GBT
1316
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2K ﹤0.01%
44
BRCN
1317
DELISTED
Burcon NutraScience Corporation
BRCN
$2K ﹤0.01%
+700
New +$2.24K
XLRN
1318
DELISTED
Acceleron Pharma
XLRN
$2K ﹤0.01%
19
XEC
1319
DELISTED
CIMAREX ENERGY CO
XEC
$2K ﹤0.01%
21
PFPT
1320
DELISTED
Proofpoint, Inc.
PFPT
$2K ﹤0.01%
11
+6
+120% +$974
AAP icon
1321
Advance Auto Parts
AAP
$3.36B
$1K ﹤0.01%
+5
New +$981
ACIW icon
1322
ACI Worldwide
ACIW
$5.83B
$1K ﹤0.01%
40
+26
+186% +$1.02K
AHT
1323
Ashford Hospitality Trust
AHT
$21M
$1K ﹤0.01%
3
ALGS icon
1324
Aligos Therapeutics
ALGS
$28.5M
$1K ﹤0.01%
1
ALLK
1325
DELISTED
Allakos
ALLK
$1K ﹤0.01%
7

Similar funds

Newbridge Financial Services Group's Q2 2021 Portfolio in Review

As of Q2 2021, Newbridge Financial Services Group held 1,560 positions worth $163M, up 20% from $136M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Newbridge Financial Services Group deployed $14.4M of net new capital in Q2 2021, opening 190 new positions and adding to 483 existing holdings. Its largest new stake was Adaptive Alpha Opportunities ETF: 83,683 shares worth $2.19M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $696K trimmed.

  • Newbridge Financial Services Group's largest Q2 2021 buy was Adaptive Alpha Opportunities ETF: 83,683 shares worth $2.19M.
  • Newbridge Financial Services Group added most to Tesla in Q2 2021, an estimated $937K increase.
  • Newbridge Financial Services Group's biggest Q2 2021 reduction was Alphabet (Google) Class A, cutting an estimated $696K.
  • Newbridge Financial Services Group fully exited FS KKR Capital Corp. II in Q2 2021, selling an estimated $130K.
  • Newbridge Financial Services Group's ten largest holdings make up 23% of its $163M portfolio in Q2 2021.
  • Newbridge Financial Services Group opened 190 new positions and closed 58 in Q2 2021.
  • Newbridge Financial Services Group's portfolio value rose 20% quarter-over-quarter to $163M.

Based on Newbridge Financial Services Group's 13F filing for Q2 2021, filed 7 Sep 2021.